Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity
Socinski, M. A., Zhang, C., Herndon, J. E., Dillman, R. O., Clamon, G., Vokes, E., Akerley, W., Crawford, J., Perry, M. C., Seagren, S. L., Green, M. R.
Published in Annals of oncology (01.07.2004)
Published in Annals of oncology (01.07.2004)
Get full text
Journal Article
Long-term complication risk after very high dose thoracic radiotherapy
Anscher, M.S, Marks, L.B, Shafman, T.D, Clough, R, Huang, H, Tisch, A, Munley, M, Herndon, J.E, Garst, J, Crawford, J, Jirtle, R.L
Published in International journal of radiation oncology, biology, physics (01.10.2002)
Published in International journal of radiation oncology, biology, physics (01.10.2002)
Get full text
Journal Article
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
Rocha-Lima, C.M., Herndon, J.E., Lee, M.E., Atkins, J.N., Mauer, A., Vokes, E., Green, M.R.
Published in Annals of oncology (01.02.2007)
Published in Annals of oncology (01.02.2007)
Get full text
Journal Article
TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL
Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., Grollman, A. P., He, T. C., He, Y., Hruban, R. H., Jallo, G. I., Mandahl, N., Meeker, A. K., Mertens, F., Netto, G. J., Rasheed, B. A., Riggins, G. J., Rosenquist, T. A., Schiffman, M., Shih, I., Theodorescu, D., Torbenson, M. S., Velculescu, V. E., Wang, T. L., Wentzensen, N., Wood, L. D., Zhang, M., Healy, P., Yang, R., Diplas, B., Wang, Z. H., Greer, P., Zhu, H. S., Wang, C., Carpenter, A., Herndon, J. E., McLendon, R. E., Kinzler, K. W., Vogelstein, B., Papadopoulos, N., Bigner, D. D.
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.07.2014)
Get full text
Journal Article
Erratum: Phase 2 pilot study of Pathfinders: a psychosocial intervention for cancer patients
Abernethy, A. P., Herndon, J. E., Coan, A., Staley, T., Wheeler, J. L., Rowe, K., Smith, S. K., Shaw, H., Lyerly, H. K.
Published in Supportive care in cancer (01.03.2011)
Published in Supportive care in cancer (01.03.2011)
Get full text
Journal Article
2498
Anscher, M.S., Garst, J., Marks, L.B., Larrier, N., Dunphy, F., Herndon, J.E., Clough, R., Marino, C., Vujaskovic, Z., Zhou, S.
Published in International journal of radiation oncology, biology, physics (01.11.2006)
Published in International journal of radiation oncology, biology, physics (01.11.2006)
Get full text
Journal Article
2498: A Phase I Study to Assess the Ability of the Anti-Cytokine Agent Thalidomide to Modulate Radiation-Induced Lung Injury
Anscher, M.S., Garst, J., Marks, L.B., Larrier, N., Dunphy, F., Herndon, J.E., Clough, R., Marino, C., Vujaskovic, Z., Zhou, S.
Published in International journal of radiation oncology, biology, physics (2006)
Published in International journal of radiation oncology, biology, physics (2006)
Get full text
Journal Article
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
Rocha Lima, C. M., Rizvi, N. A., Zhang, C., Herndon, J. E., Crawford, J., Govindan, R., King, G. W., Green, M. R.
Published in Annals of oncology (01.03.2004)
Published in Annals of oncology (01.03.2004)
Get full text
Journal Article
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study
Kornblith, A. B., Herndon ll, J. E., Zuckerman, E., Godley, P. A., Savarese, D., Vogelzang, N. J., Holland, J. C.
Published in Annals of oncology (01.05.2001)
Published in Annals of oncology (01.05.2001)
Get full text
Journal Article
70 Gy thoracic radiotherapy (TRT) is feasible concurrent with chemotherapy for limited stage small cell lung cancer (L-SCLC): preliminary analysis of a CALGB phase II trial
Bogart, J.A, Herndon, J.E, Lyss, A.P, Watson, D, Miller, A.A, Lee, M.E, Turrisi, A.T, Green, M.R
Published in International journal of radiation oncology, biology, physics (01.10.2002)
Published in International journal of radiation oncology, biology, physics (01.10.2002)
Get full text
Journal Article
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors
Kornblith, A. B., Herndon, J. E., Zuckerman, E., Cella, D. F., Cherin, E., Wolchok, S., Weiss, R. B., Diehl, L. F., Henderson, ., Cooper, M. R., Schiffer, C., Canellos, G. P., Mayer, R. J., Silver, R. T., Schilling, A., Peterson, B. A., Greenberg, D., Holland, J. C.
Published in Annals of oncology (01.03.1998)
Published in Annals of oncology (01.03.1998)
Get full text
Journal Article
Using changes in plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation for non-small cell lung cancer
Anscher, M.S., Marks, L.B., Shafman, T.D., Munley, M., Herndon, J.E., Garst, J., Crawford, J., Jirtle, R.L.
Published in International journal of radiation oncology, biology, physics (01.11.2001)
Published in International journal of radiation oncology, biology, physics (01.11.2001)
Get full text
Journal Article
O-277 CALGB 9732: Final report of a randomized phase III intergroup trial of etoposide(VP-16) and cisplatin (DDP) with or without paclitaxel(TAX) and G-CSF in patients with extensive stage small cell lung cancer(ED-SCLC)
Niell, Harvey B., Herndon, J.E., Miller, A.A., Watson, D.M., Sandler, A., Kelly, K., Marks, R., Perry, M.C., Vokes, E.E., Green, M.R.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2003)
Get full text
Journal Article
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234
Vogelzang, N. J., Herndon, J. E., Miller, A., Strauss, G., Clamon, G., Stewart, F. M., Aisner, J., Lyss, A., Cooper, M. R., Suzuki, Y., Green, M. R.
Published in Annals of oncology (01.05.1999)
Published in Annals of oncology (01.05.1999)
Get full text
Journal Article
CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)
Vokes, E.E, Leopold, K.A, Herndon, J.E, Crawford, J, Perry, M.C, Miller, A.A, Green, M.R
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2000)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2000)
Get full text
Journal Article
236 Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (INDCT) followed by concomitant chemoradiotherapy (XRT) in stage IIIB non small cell lung cancer (NSCLC): Toxicity data (CALGB study 9431)
Vokes, E.E., Leopold, K.A., Herndon, J.E., Crawford, J., Cooper, M.R., Clamon, G., Epstein, J.M., Green, M.R.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.1997)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.1997)
Get full text
Journal Article
Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer : a randomized phase II study of the cancer and leukemia group B
VOKES, E. E, LYSS, A. P, HERNDON, J. E, COOPER, B, PERRY, M. C, VINCIGUERRA, V, MASON-COUGHLIN, K, GREEN, M. R
Published in Annals of oncology (01.11.1992)
Published in Annals of oncology (01.11.1992)
Get full text
Journal Article
Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study
Kelsey, C R, Scott, J M, Lane, A, Schwitzer, E, West, M J, Thomas, S, Herndon II, J E, Michalski, M G, Horwitz, M E, Hennig, T, Jones, L W
Published in Bone marrow transplantation (Basingstoke) (01.10.2014)
Published in Bone marrow transplantation (Basingstoke) (01.10.2014)
Get full text
Journal Article